Chimera Investment Corporation's preferred share CIM-A is trading significantly above its buy target at 110.7%, despite a 9.27% yield, making it overpriced. In contrast, CIM-B offers a higher stripped yield of 10.24% and trades near its buy target, providing better income for similar risk. CIM-A's fixed coupon rate is less valuable given its premium price and available alternatives. Both shares carry high risk due to weak equity coverage, but CIM-B currently represents the better value for investors seeking income in Chimera's preferred shares and baby bonds.
Alibaba and NetEase are set to report earnings simultaneously, offering investors a choice between Alibaba's AI and cloud growth story and NetEase's cash-generative gaming business. Analysts show strong bullish sentiment for both, with NetEase having...
Aurora Innovation's stock fell 11.8% to $6.15 after reporting Q2 FY2026 revenue of $2 million, beating estimates, but with a widened net loss of $270 million. The company leads in driverless Class 8 trucks with strong operational milestones and regul...
Medical Properties Trust (MPT) arranged a $2.4 billion financing package that extends its major debt maturities to 2032, removing immediate refinancing risks but increasing interest expenses due to new 9.25% Senior Notes. The company faces a $0.057 p...
Conduent's Q2 FY2026 report revealed mostly disappointing results, although the company successfully sold two business units at favorable multiples compared to the overall company valuation. The outlook for the full fiscal year suggests a stronger se...
Kenon Holdings Ltd. is benefiting from favorable market conditions in the US PJM energy market and improving margins in its Israeli business through OPC Energy. The company is expanding capacity and margins, supporting long-term growth. It currently ...
